Delcath Systems DCTH Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Product revenue by Product | ||||||
| CHEMOSAT | $6.38M+15.4% | $6.4M+30.5% | $6.14M+52.4% | $5.99M+81.6% | $5.53M+113% | |
| HEPZATO KIT | $84.06M+74.0% | $78.84M+144% | $73.46M+295% | $64.25M+649% | $48.32M+2,306% | |
| Number of orphan drug designations granted by FDA by Product | ||||||
| HEPZATO KIT, Doxorubicin | 4— | 4— | 4— | 4— | —— | |
| HEPZATO KIT, Melphalan | 20— | 20— | 20— | 20— | —— | |
| HEPZATO KIT | 24— | 24— | 24— | 24— | —— | |
| Operating Lease, Payments by Geography | ||||||
| Ireland | $46K+2.2% | $46K+7.0% | $35K-10.3% | $44K+10.0% | $45K+36.4% | |
| U.S. | $144K-5.3% | $144K+20.0% | $152K+100% | $152K+56.7% | $152K+4.8% | |
| Lessee, Operating Lease, Liability, to be Paid by Geography | ||||||
| Ireland | $132K-55.1% | $175K-47.9% | $213K-44.7% | $256K-39.5% | $294K-33.9% | |
| U.S. | $5.05M-10.2% | $5.19M-10.0% | $5.34M+21.8% | $5.48M+85.3% | $5.63M+262% | |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount by Geography | ||||||
| Ireland | $4K-78.9% | $7K-70.8% | $10K-67.7% | $14K-64.1% | $19K-56.8% | |
| U.S. | $1.38M-18.2% | $1.45M-17.7% | $1.53M+12.9% | $1.61M+74.1% | $1.68M+257% | |
| Weighted average discount rate - operating leases by Geography | ||||||
| Ireland | 32%0.0pp | 32%0.0pp | 32%0.0pp | 32%0.0pp | 32%0.0pp | |
| U.S. | 32%0.0pp | 32%0.0pp | 32%0.0pp | 32%0.0pp | 32%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Delcath Systems break its business down?
- Delcath Systems (DCTH) reports product revenue by product across 2 parts — CHEMOSAT and HEPZATO KIT. Each is extracted from the segment footnotes and tracked over time.
- Where does Delcath Systems's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Delcath Systems's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
